COVID-19 vaccine Adverse Response & Evaluation (CARE) Programme:
Part IV of the study aims to actively recruit participants and intensively monitor their potential adverse reactions
The study aims to understand the potential adverse reactions seen in people of different age groups and health statues following COVID-19 vaccination.
This study will be conducted in the form of follow-up surveys
Each vaccine recipient or their caregiver completed an online or paper survey 1, 2, 3, 7, 14 & 28 days after each COVID-19 vaccine injection (two doses in total), a maximum of 12 surveys.
The survey recorded the health status and any adverse reactions seen in the vaccine recipient.
As of 13/08/2021